# IRRAS

Type: Company

Source: Biotech Intelligence Brief — https://getbiobrief.com/entity/irras
Canonical HTML page: https://getbiobrief.com/entity/irras

## Recent coverage (1 stories)

### ClearPoint Neuro Reports 18% Revenue Growth, Eyes $56M Target for 2026
2026-03-18 00:45:10 · Sentiment: Neutral · Impact: 5/10 · Sources: 2

ClearPoint Neuro (CLPT) achieved record full-year 2025 revenue of $37 million, driven by a 23% fourth-quarter surge in its Biologics and Drug Delivery segment. The company is pivoting toward a higher-growth profile through the integration of Eris Holdings and IRRAS, setting an ambitious revenue target of up to $56 million for 2026.
Full story: https://getbiobrief.com/story/clearpoint-neuro-2025-earnings-biologics-growth

---
This page is a machine-readable summary. Sentiment measures the directional read of each development for this entity, not the tone of the reporting; impact weights consequence, not syndication reach. See https://getbiobrief.com/guides/methodology for the full editorial methodology.